While new assays have retained interest in the information DNA microarrays can give us, omics technologists have fixed their sights on a new challenge: printing protein microarrays. It is ...

Protein-binding microarray (PBM) technology provides a rapid, high-throughput means of characterizing the in vitro DNA-binding specificities of transcription factors (TFs). Using high-density ...

Protein microarrays were developed by utilizing the technology of DNA microarrays, which are commonly used to analyze gene expression. The requirements of protein microarrays are, however ...

Microarrays find their place in epitope mapping ... properties are detected by developing new assays to characterize protein-DNA and for protein–peptide interaction. Test ligands are directly ...

Microarrays permit the analysis of gene expression, DNA sequence variation, protein levels, tissues, cells and other biological and chemical molecules in a massively parallel format. Robust ...

Cell-based technologies for printing protein microarrays are faced with poor protein expression, protein insolubility, improper folding and poor shelf life. Cell-free expression-based protein ...

Although powerful, microarray chips did not provide any information about the proteins bound to the DNA and how they might affect gene expression. To uncover the sites of protein-DNA interactions at ...

Courtesy of CombiMatrix A number of companies are using the lessons and technologies of traditional genomics--the microarray chief among them--to ... lack the high-throughput capacity of their DNA and ...

There is a wide range of techniques used, including DNA microarray analysis and serial ... mass spectrometry, and protein microarrays. Bioinformatics, although not graced with the -omics suffix ...

Launched in 1990, The Human Genome Project was a monumental effort to sequence and analyze the entire human genome to understand how genetics influence health. While the Human Genome Project helped ...

Except for hypothetical protein XP_373908 ... phage-peptide clones assessed with the use of publicly available DNA microarray data on the Web site of Oncomine (www.oncomine.org).